More recently, Decombis et al. demonstrated that MCL cells also present a tumor-specific secretion of interleukin-32 beta (IL32β) through CD40-L-mediated interaction with the TME, but also IL32 locus hypomethylation. The gene discussed is CD40LG; the disease is neoplasm.